natgillin/translations-raw huggingface dataset:
Clopidogrel ratiopharm contains hydrogenated castor oil which may cause stomach upset and
Klopidogrel ratiopharm vsebuje hidrogenirano ricinusovo olje, ki lahko razdraži želodec in povzroči drisko.
Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain;
Zelo redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): zlatenica, huda bolečina v trebuhu z ali brez bolečine v hrbtu, zvišana telesna temperatura, težave pri dihanju, ki so včasih povezane s kašljem, splošne alergijske reakcije (na primer, splošni občutek toplote z nenadnim nelagodjem do nezavesti), oteklina v ustih, mehurji na koži, kožna alergija, vnetje v ustih (stomatitis), znižanje krvnega tlaka, zmedenost, halucinacije, bolečine v sklepih, bolečine v mišicah, motnje v okušanju hrane.
a recent serious injury a recent surgery (including dental) a planned surgery (including dental) in the next seven days if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the if you have had an allergy or reaction to any medicine used to treat your disease
nedavna huda poškodba nedaven kirurški poseg (vključno na zobeh) načrtovan kirurški poseg (vključno na zobeh) v naslednjih 7 dneh
Clopidogrel ratiopharm contains hydrogenated castor oil This may cause stomach upset or diarrhoea.
Zdravila Klopidogrel ratiopharm vsebuje hidrogenirano ricinusovo olje To lahko povzroči želodčne motnje ali drisko.
Therapeutic experience is limited in patients with renal impairment (see section 4.4).
• Okvara ledvic Terapevtske izkušnje pri bolnikih z okvaro ledvic so omejene (glejte poglavje 4.4).
While you are taking Clopidogrel ratiopharm:
Ko jemljete zdravilo Klopidogrel ratiopharm:
Serum sickness, anaphylactoid reactions, cross-reactive drug hypersensitivity among thienopyridines (such as ticlopidine, prasugrel) (see section 4.4)* Hallucinations, confusion
Serumska bolezen, anafilaktoidne reakcije, navzkrižna preobčutljivost med tienopiridini (kot sta tiklopidin in prasugrel) (glejte poglavje 4.4)*
Patients should be evaluated for history of hypersensitivity to another thienopyridine (such as ticlopidine, prasugrel) since allergic cross-reactivity among thienopyridines has been reported (see section 4.8).
Pri bolnikih je treba preveriti anamnezo preobčutljivosti na druge tienopiridine (kot sta npr. tiklopidin in prasugrel), ker so poročali o navzkrižnih alergijah med tienopiridini (glejte poglavje 4.8).
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE CONDITIONS OR RESTRICTIONS REGARDING SUPPLY
A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA
Clopidogrel ratiopharm is unlikely to affect your ability to drive or to use machines.
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel ratiopharm vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents and GPIIb/IIIa antagonists without evidence of clinically
Vendar pa so bolniki, ki so bili vključeni v klinično preskušanje klopidogrela, prejemali sočasno različna zdravila, vključno z diuretiki, zaviralci adrenergičnih receptorjev beta, zaviralci angiotenzinske konvertaze (ACEI), kalcijevimi antagonisti, učinkovinami za zniževanje holesterola, koronarnimi vazodilatatorji, antidiabetiki (vključno z insulinom), antiepileptičnimi učinkovinami in antagonisti glikoproteina IIb/IIIa, brez dokazov o klinično pomembnih neželenih interakcijah.
As a precautionary measure, breast-feeding should not be continued during treatment with clopidogrel.
Iz varnostnih razlogov naj se z dojenjem med zdravljenjem z zdravilom Klopidogrel ratiopharm ne nadaljuje.
In a subgroup analysis by qualifying condition (myocardial infarction, ischaemic stroke, and PAD) the benefit appeared to be strongest (achieving statistical significance at p=0.003) in patients enrolled due to PAD (especially those who also had a history of myocardial infarction) (RRR = 23.7%; CI: 8.9 to
Pri analizi podskupin glede na vključitveni pogoj (miokardni infarkt, ishemična kap in periferna arterijska bolezen/PAD/) je videti najmočnejšo korist (doseganje statistične značilnosti pri p=0,003) pri bolnikih, vključenih zaradi PAD (zlasti pri tistih, ki so doživeli tudi miokardni infarkt) (zmanjšanje RT=23,7 %; IZ: 8,9 do 36,2), in šibkejšo (ni bila pomembno različna od ASA) pri bolnikih s kapjo (zmanjšanje RT=7,3 %; IZ: -5,7 do 18,7 [p=0,258]).
Talk to your doctor or pharmacist before taking Clopidogrel ratiopharm: if you have a risk of bleeding such as a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer) a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
• če imate tveganje za krvavitev, kot je: zdravstveno stanje s tveganjem za notranjo krvavitev (kot je rana na želodcu) krvna motnja, zaradi katere ste bolj nagnjeni k notranji krvavitvi (krvavitev v tkivih, organih ali sklepih vašega telesa).
No effect on hepatic metabolising enzymes was observed in humans receiving clopidogrel at the
Nobenega učinka na presnovne encime niso opazili pri ljudeh ob prejemanju terapevtskih odmerkov.
NAME OF THE MARKETING AUTHORISATION HOLDER
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM
Gastrointestinal and retroperitoneal haemorrhage with fatal outcome, pancreatitis, colitis (including ulcerative or lymphocytic colitis), stomatitis Acute liver failure, hepatitis, abnormal liver function test Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous, urticaria, eczema, lichen planus Musculo-skeletal bleeding (haemarthrosis), arthritis, arthralgia, myalgia
Bulozen dermatitis (toksična epidermalna nekroliza, StevensJohnsonov sindrom, multiformni eritem), angioedem, z zdravili povzročen sindrom preobčutljivosti (sindrom DIHS, Drug-Induced Hypersensitivity Syndrome), kožni izpuščaj z eozinofilijo in sistemskimi simptomi, kot posledica zdravljenja z zdravilom (sindrom DRESS, Drug Rash with Eosinophilia and Systemic Symptoms), eritematozen izpuščaj, urtikarija, ekcem, lihen planus
- For more than 12 hours: patients should take the next dose at the regular scheduled time
če je zamuda več kot 12 ur: bolnik naj naslednji odmerek vzame ob pravem času; odmerka ne sme podvojiti.
You have a condition of hardening of arteries (also known as atherosclerosis), and You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease (disturbed blood flow in arms or legs caused by vascular
Zdravilo Klopidogrel ratiopharm vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen (moten krvni pretok v rokah ali nogah, ki ga povzroči zapora žil)
Do not take a double dose to
Ne vzemite dvojnega odmerka, da bi nadomestili izpuščeno tableto.
Pharmacotherapeutic group: platelet aggregation inhibitors excl. heparin,
Farmakoterapevtska skupina: Zaviralci agregacije trombocitov brez heparina, oznaka ATC: B01AC04.
Clopidogrel should be given as a single daily dose of 75 mg. - Within less than 12 hours after regular scheduled time: patients should take the dose immediately and then take the next dose at the regular scheduled time.
Če bolnik izpusti odmerek: če je zamuda manj kot 12 ur po pravem času: bolnik naj odmerek vzame takoj, potem pa naslednji odmerek ob pravem času.
What Clopidogrel ratiopharm looks like and contents of the pack Clopidogrel ratiopharm 75 mg film-coated tablets are white to off-white, marbled, round and biconvex.
Klopidogrel ratiopharm 75 mg tablete so bele do belkaste, marmorirane, okrogle, bikonveksne filmsko obložene tablete.
Serious haemorrhage, haemorrhage of operative wound, vasculitis, hypotension Respiratory tract bleeding (haemoptysis, pulmonary haemorrhage), bronchospasm, interstitial pneumonitis
Krvavitve v dihalih (hemoptiza, pljučna krvavitev), bronhospazem, intersticijski pnevmonitis
- fluoxetine, fluvoxamine, or moclobemide, medicines to treat depression - carbamazepine, or oxcarbazepine, medicines to treat some forms of epilepsy
• fluoksetin, fluvoksamin ali moklobemid, zdravila za zdravljenje depresije,
Furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the coadministration of
Poleg tega na farmakodinamično aktivnost klopidogrela ni pomembno vplivala sočasna uporaba fenobarbitala ali estrogena.
Detailed information on this medicinal product is available on the website of the European Medicines
DATUM ZADNJE REVIZIJE BESEDILA Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/.
Cellulose, microcrystalline (E460) Crospovidone type A Castor oil, hydrogenated
jedro tablete: makrogol 6000 mikrokristalna celuloza (E460) krospovidon (vrsta A) hidrogenirano ricinusovo olje filmska obloga: makrogol 6000 etilceluloza (E462) titanov dioksid (E171)
Tests are available to identify a patient's CYP2C19 genotype (see section 5.2).
Na voljo so testi za ugotavljanje bolnikovega CYP2C19-genotipa.
Teva Norway AS Tlf: +47 66 77 55 90
Teva Denmark ApS Tlf: +45 44 98 55 11
Contact your doctor immediately if you experience: fever, signs of infection or extreme tiredness.
- zvišana telesna temperatura, znaki okužbe ali huda utrujenost.
Contact your doctor or pharmacist before
Posvetujte se s svojim zdravnikom ali farmacevtom, preden prekinete zdravljenje.
Contents of the pack and other information What Clopidogrel ratiopharm contains
Shranjevanje zdravila Klopidogrel ratiopharm Vsebina pakiranja in dodatne informacije
If you forget to take Clopidogrel ratiopharm
Kako jemati zdravilo Klopidogrel ratiopharm
Tablet core:
7 tablet
Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1 97 007
ratiopharm Arzneimittel Vertriebs-GmbH
- heparin or any other injectable medicine used to reduce blood clotting - omeprazole, esomeprazole or cimetidine, medicines to treat upset stomach - fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and
• flukonazol, vorikonazol, ciprofloksacin ali klorampfenikol, zdravila za zdravljenje bakterijskih in glivičnih okužb,
Gastrointestinal disorders
Bolezni imunskega
OTHER CONDITIONS AND REQUIREMENTS OF THE
Splošne težave in spremembe na mestu aplikacije
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT
Še posebej pomembno je, da obvestite zdravnika, če jemljete
Macrogol 6000
100 tablet
Gastric ulcer and duodenal ulcer, gastritis, vomiting, nausea, constipation, flatulence
Krvavitev v prebavila in retroperitonealna krvavitev s smrtnim izidom, pankreatitis, kolitis (vključno z ulceroznim ali limfocitnim kolitisom), stomatitis
Diarrhoea, abdominal pain, indigestion or heartburn.
Bolezni dihal, prsnega koša in mediastinalnega prostora
You will hear a “click”.
Pri tem boste zaslišali “klik”.
• alcohol wipes or similar.
• alkoholne krpice ali podobno
• think you may be pregnant; or
• mislite, da bi utegnili biti noseči; ali
Please tell your doctor:
Prosimo, povejte svojemu zdravniku
Some changes may occur in your blood, but these will be detected by routine blood tests.
Pojavijo se lahko spremembe v krvi, vendar jih zaznamo z rutinskimi krvnimi preiskavami.
Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/
Podrobni podatki o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (EMEA) http://www.emea.europa.eu/
OTHER SPECIAL WARNING(S), IF NECESSARY Avoid vigorous shaking.
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA Izogibajte se močnemu stresanju!
Date of last renewal: 16 July 2007
Datum podaljšanja dovoljenja za promet: 16. julij 2007
The inspection window will be green, confirming the injection is complete.
Kontrolno okence bo zeleno, kar dokazuje, da je injiciranje dokončano.
White blood cells are important as they help your body fight infection.
Bele krvničke so pomembne, ker pomagajo vašemu telesu boriti se proti okužbam.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 22 August 2002
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 22. avgust 2002
Neupopeg should not be used during pregnancy unless clearly necessary.
Neupopega med nosečnostjo ne smete uporabljati, razen če je to očitno potrebno.
• Do not put the cover back on used needles.
• Ne nameščajte pokrovčka nazaj na uporabljene igle.
Store in a refrigerator (2°C - 8°C).
Shranjujte v hladilniku (2 °C - 8 °C ).
Pharmacotherapeutic group: Cytokines, ATC Code: L03AA13
Farmakoterapevtska skupina: Citokini, oznaka ATC: L03AA13
Name and address of the manufacturer of the biological active substance
Ime in naslov izdelovalca biološko aktivne substance
WHAT NEUPOPEG IS AND WHAT IT IS USED FOR
KAJ JE NEUPOPEG IN ZA KAJ GA UPORABLJAMO
There are no adequate data from the use of pegfilgrastim in pregnant women.
O uporabi pegfilgrastima pri nosečnicah ni zadostnih podatkov.
If you use more Neupopeg than you should
Če ste uporabili večji odmerek Neupopega, kot bi smeli
Your doctor has given you Neupopeg to encourage your bone marrow (part of the bone which makes blood cells) to produce more white blood cells that help your body fight infection.
Vaš zdravnik vam je predpisal Neupopeg, da bi spodbudil vaš kostni mozeg (tisti del kosti, ki izdeluje krvničke) k izdelavi več belih krvničk, ki pomagajo vašemu telesu boriti se proti okužbam.
6.6 Special precautions for disposal and other handling The carton contains a package leaflet with the full instructions for use and handling.
6.6 Posebni varnostni ukrepi za odstranjevanje Škatla vsebuje navodilo za uporabo z natančnimi navodili za uporabo in rokovanje.
Do not warm Neupopeg in any other way (for example, do not warm it in a microwave or in hot water).
Neupopega ne smete segrevati na kak drug način (na primer v mikrovalovni pečici ali v vroči
Put the needle fully into the skin as shown by your nurse or doctor.
Potisnite iglo do konca v kožo, kot vam je pokazal zdravnik ali medicinska sestra.
• Disinfect your skin by using an alcohol wipe.
• Razkužite si kožo z alkoholno krpico
Nausea was observed in healthy volunteers and patients receiving chemotherapy.
Navzejo so opazili pri zdravih prostovoljcih in pri bolnikih, ki so dobivali kemoterapijo.
If you experience difficulties choose a more firm injection site.
Če se pojavijo težave, izberite čvrstejše mesto za injiciranje.
Not all pack sizes may be marketed.
Na trgu morda ni vseh pakiranj.
If you forget to inject Neupopeg
Če ste si pozabili injicirati Neupopeg
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Neupopeg.
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se z njim posvetujte, preden uporabite zdravilo Neupopeg.
• Remove the grey needle shield (see picture 2).
• Snemite sivi pokrovček igle (glejte sliko 2).
Pack size of one, for single use only.
Pakiranje po ena, za enkratno uporabo.
• if you have sickle cell anaemia;
• če imate srpasto anemijo;
It belongs to a group of proteins called cytokines, and is very similar to a natural protein (granulocyte-colony stimulating factor) produced by your own body.
Spada v skupino beljakovin, imenovanih citokini, in je zelo podobna naravni beljakovini (t. i. granulocitne kolonije stimulirajočemu faktorju), ki nastaja v telesu.
Possible interactions with other haematopoietic growth factors and cytokines have not been specifically investigated in clinical studies.
Možnih interakcij z drugimi hemopoetičnimi rastnimi faktorji in citokini v kliničnih študijah niso posebej raziskovali.
Therefore, physicians should exercise caution when administering Neupopeg in patients with sickle cell disease, should monitor appropriate clinical parameters and laboratory status and be attentive to the possible association of Neupopeg with splenic enlargement and vaso-occlusive crisis.
Zato morajo biti zdravniki previdni, kadar dajejo Neupopeg bolnikom s srpasto anemijo, spremljati morajo ustrezne klinične parametre in laboratorijski status in biti pozorni na morebitno povezavo Neupopega z zvečanjem vranice in vazookluzivno krizo.
Specific interaction or metabolism studies have not been performed, however, clinical studies have not indicated an interaction of Neupopeg with any other medicinal products.
Posebnih študij medsebojnega delovanja ali presnove niso opravili, vendar klinične raziskave niso pokazale medsebojnega delovanja Neupopega s kakšnimi drugimi zdravili.
However, the long-term effects of Neupopeg have not been established in acute myeloid leukaemia; therefore, it should be used with caution in this patient population.
Vendar dolgoročni učinki zdravila Neupopeg pri akutni mieloični levkemiji niso ugotovljeni, zato ga je treba pri tej populaciji bolnikov uporabljati previdno.
Neupopeg therapy should be initiated and supervised by physicians experienced in oncology and/or haematology.
Zdravljenje z Neupopegom morajo uvesti in nadzorovati zdravniki, izkušeni v onkologiji in/ali hematologiji.
B CONDITIONS OF THE MARKETING AUTHORISATION
B POGOJI DOVOLJENJA ZA PROMET Z DRAVILOM
Choose a site at least 5 cm away from the belly button (navel) (see picture 4).
Izberite primerno mesto, ki je vsaj 5 cm oddaljeno od popka (glejte sliko 4).
Similarly to filgrastim, neutrophils produced in response to pegfilgrastim show normal or enhanced function as demonstrated by tests of chemotactic and phagocytic function.
Podobno kot pri filgrastimu nevtrofilci, ki nastanejo v odgovor na pegfilgrastim, kažejo normalno ali zvečano delovanje, kot kažejo testi kemotaktične in fagocitne funkcije.
If you have forgotten a dose of Neupopeg, you should contact your doctor to discuss when you should inject the next dose.
Če ste pozabili odmerek Neupopega, se posvetujte z zdravnikom glede tega, kdaj si boste injicirali naslednji odmerek.
Some of the reported cases have resulted in respiratory failure or Adult Respiratory Distress Syndrome (ARDS), which may be fatal (see section 4.4)
V nekaterih opisanih primerih je prišlo do respiracijske insuficience ali sindroma akutne dihalne stiske (ARDS), ki sta lahko usodna (glejte poglavje 4.4).
Such elevation in white blood cells is transient, typically seen 24 to 48 hours after administration and is consistent with the pharmacodynamic effects of Neupopeg.
Takšno zvišanje belih krvničk je prehodno, opazimo ga tipično 24 do 48 ur po uporabi zdravila in se sklada s farmakodinamskimi učinki Neupopega.
If needed, you may cover the injection site with a bandage.
Če je potrebno, lahko injekcijsko mesto prekrijete s povojem.
Find a comfortable, well-lit, clean place and put all the equipment you need within reach.
Poiščite si udoben, dobro osvetljen prostor in si pripravite vse, kar boste potrebovali, tako da bo
If you want more information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
Safety cover out
Varnostni pokrovček umaknjen
Disinfect your skin by using an alcohol wipe and pinch the skin between your thumb and forefinger, without squeezing it.
Razkužite si kožo z alkoholno krpico in primite kožo s palcem in kazalcem, ne da bi jo stiskali.
The safety and efficacy of Neupopeg for the mobilisation of blood progenitor cells in patients or healthy donors has not been adequately evaluated.
Varnosti in učinkovitosti Neupopega za mobilizacijo matičnih krvotvornih celic pri bolnikih ali zdravih dajalcih niso primerno ovrednotili.
This is called a subcutaneous injection.
Temu pravimo subkutano injiciranje.
How to give an injection into the thigh or back of the arm
Kako dati injekcijo v stegno ali zadnji del nadlakta
What should I do before I give myself a subcutaneous injection of Neupopeg?
Kaj moram narediti, preden si dam subkutano injekcijo Neupopega?
In animal models concomitant administration of Neupopeg and 5-fluorouracil (5-FU) or other antimetabolites has been shown to potentiate myelosuppression.
Pokazali so, da v živalskih modelih sočasna uporaba Neupopega in 5-fluorouracila (5-FU) ali drugih antimetabolitov okrepi mielosupresijo.
Neupopeg contains less than 1 mmol (23 mg) sodium per 6 mg dose, i.e. essentially ‘sodium-free'.
Neupopeg vsebuje manj kot 1 mmol (23 mg) natrija na 6 mg odmerek, kar v bistvu pomeni ˝brez natrija˝.
The onset of pulmonary signs such as cough, fever, and dyspnoea in association with radiological signs of pulmonary infiltrates, and deterioration in pulmonary function along with increased neutrophil count may be preliminary signs of Adult Respiratory Distress Syndrome (ARDS).
Pojav pljučnih znakov, kot so kašelj, zvišana telesna temperatura in dispneja v povezavi z radiološkimi znaki pljučnih infiltratov, in poslabšanje pljučne funkcije skupaj z zvečanim številom nevtrofilcev utegnejo biti preliminarni znaki sindroma dihalne stiske odraslih (ARDS - 'Adult Respiratory Distress Syndrome').
After use (needle safety cover down)
Po uporabi (varnostni pokrovček je spuščen)
In clinical studies, Neupopeg has been safely administered 14 days before chemotherapy.
V kliničnih študijah so Neupopeg varno dajali 14 dni pred kemoterapijo.
Neupopeg left at room temperature for more than 72 hours should be discarded.
Neupopeg, ki je bil na sobni temperaturi več kot 72 ur, je treba zavreči.
Pinch the skin of the abdomen firmly between the thumb and fingers creating a space at least 3 cm wide (twice the width of the tip of the pre-filled pen).
Trdno primite kožo na trebuhu med palec in kazalec, tako da boste oblikovali vsaj 3 cm široko kožno gubo (dvakratna širina konice napolnjenega injekcijskga peresnika).
The safety and efficacy of Neupopeg administration in de novo AML patients aged < 55 years with cytogenetics t(15;17) have not been established.
Varnost in učinkovitost Neupopega pri bolnikih z de novo AML, mlajših od 55 let in s citogenetiko t(15;17), nista ugotovljeni.
Inject the liquid slowly and evenly, always keeping your skin pinched.
Tekočino injicirajte počasi in enakomerno; pri tem ves čas s palcem in kazalcem držite kožno
The safety and efficacy of Neupopeg have not been investigated in patients with myelodysplastic syndrome, chronic myelogenous leukaemia, and in patients with secondary Acute Myeloid Leukaemia (AML); therefore, it should not be used in such patients.
Varnost in učinkovitost zdravila Neupopeg nista raziskani pri bolnikih z mielodisplastičnim sindromom, kronično mielogeno levkemijo in s sekundarno akutno mieloično levkemijo (AML), zato ga pri takšnih bolnikih ne smete uporabljati.
Do not remove the cover from the syringe until you are ready to inject.
Ne snemite pokrovčka z injekcijske brizge, dokler niste pripravljeni na vbrizgavanje.
C. After the second “click” (or a count of 15) lift the pre-filled pen from the injection site.
C. Ko boste zaslišali drugi “klik” (ali prešteli do 15), dvignite napolnjeni injekcijski peresnik z mesta za injiciranje.
Do not shake Neupopeg vigorously as this may affect its activity
Zdravila Neupopeg ne smete močno stresati, ker to lahko vpliva na njegovo delovanje.
Before use (without grey needle shield)
Pred uporabo (brez sivega pokrovčka igle)